Literature DB >> 10540319

Reduced antilisterial activity of TNF-deficient bone marrow-derived macrophages is due to impaired superoxide production.

M Müller1, R Althaus, D Fröhlich, K Frei, H P Eugster.   

Abstract

Mice deficient for TNF ligand and receptor type 1 have demonstrated the importance of TNF in the host defense against Listeria monocytogenes. To investigate the particular deficiency of macrophages derived from TNF/lymphotoxin (LT)-alpha(-/-) mice in antilisterial growth control, bone marrow-derived macrophages (BMDM) were used for in vitro infection experiments. After the combined treatment with IFN-gamma and lipopolysaccharide (LPS), production of NO by wild-type (wt) and TNF/LT-alpha(-/-) BMDM was induced to comparable levels, but only wt BMDM controlled L. monocytogenes growth efficiently. Nevertheless, inhibition of NO production led to a remarkable loss of antilisterial activity. This suggests that presence of NO is necessary but not sufficient for L. monocytogenes killing and that elimination of L. monocytogenes requires additional effector molecules. The LPS-inducible superoxide production of TNF/LT-alpha(-/-) BMDM was impaired. Accordingly both scavenging of superoxide and peroxynitrite led to reduced L. monocytogenes killing by wt BMDM. In addition, peroxynitrite was able to kill L. monocytogenes in vitro. Together these findings suggest that the defective host defense of TNF/LT-alpha-deficient mice against L. monocytogenes partially stems from reduced superoxide production of macrophages due to the absence of TNF and imply a function for peroxynitrite, the reaction product of NO and superoxide, in the intracellular killing of L. monocytogenes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540319     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3089::AID-IMMU3089>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation.

Authors:  Masashi Emoto; Tomomi Yoshida; Toshio Fukuda; Ikuo Kawamura; Masao Mitsuyama; Eiji Kita; Robert Hurwitz; Stefan H E Kaufmann; Yoshiko Emoto
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

3.  Extracellular superoxide dismutase inhibits innate immune responses and clearance of an intracellular bacterial infection.

Authors:  Timothy J Break; Sujung Jun; Mohanalaxmi Indramohan; Karen D Carr; Amy N Sieve; Ladislav Dory; Rance E Berg
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

4.  Nitric oxide is protective in listeric meningoencephalitis of rats.

Authors:  K A Remer; T W Jungi; R Fatzer; M G Täuber; S L Leib
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 5.  The Essential Role of Neutrophils during Infection with the Intracellular Bacterial Pathogen Listeria monocytogenes.

Authors:  Alexandra R Witter; Busola M Okunnu; Rance E Berg
Journal:  J Immunol       Date:  2016-09-01       Impact factor: 5.422

6.  Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages.

Authors:  Jesse T Myers; Albert W Tsang; Joel A Swanson
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

7.  Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.

Authors:  Emilie Narni-Mancinelli; Laura Campisi; Delphine Bassand; Julie Cazareth; Pierre Gounon; Nicolas Glaichenhaus; Grégoire Lauvau
Journal:  J Exp Med       Date:  2007-08-13       Impact factor: 14.307

Review 8.  Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs.

Authors:  Irene Ramos; Ana Fernandez-Sesma
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.